# Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

> **NCT01410981** · — · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 73 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01410981
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2018-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01410981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01410981, "Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01410981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*